Evidence map›Paper›PMID 42846657›Full record

ArticleClinical case reports2026

Cochlear Implantation in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Jacob Mabey, Hannah Dunn, Justin Cottrell

Abstract read
In one paragraph

Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jacob MabeyDepartment of Surgery, Division of Otolaryngology-Head and Neck Surgery Yale School of Medicine New Haven Connecticut USA.ORCID https://orcid.org/0000-0003-1361-5795
Hannah DunnDepartment of Surgery, Division of Otolaryngology-Head and Neck Surgery Yale School of Medicine New Haven Connecticut USA.
Justin CottrellDepartment of Surgery, Division of Otolaryngology-Head and Neck Surgery Yale School of Medicine New Haven Connecticut USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a neuroimmunologic demyelinating disorder that may present with central or peripheral sensorineural hearing loss (SNHL). This case describes a 43-year-old female with MOGAD and profound right-sided SNHL who did not improve with neuroimmunologic therapy. Additional immunologic and radiographic workup was unrevealing. The patient underwent right cochlear implantation (CI) without complication and with significant improvement in her speech recognition. Despite the possibility of central SNHL, select patients with MOGAD may benefit from CI, and thus MOGAD should not be considered an absolute contraindication to cochlear implantation.

Indexed as

cochlear implant (CI)demyelinating disordermyelin oligodendrocyte glycoprotein antibody associated disease (MOGAD)sensorineural hearing loss (SNHL)

Identifiers

PMID42846657
PMCPMC13643042

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.